Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx INDUSTRY NEEDS TO PREPARE TO DEFEND DTC AD BUDGETS, AAAA's KAMP TELLS FDLI; FDA DTC POLICY REQUIRES "SERIOUS" ENFORCEMENT BY AGENCY -- FDA'S SCHULTZ

Executive Summary

Pharmaceutical companies need to prepare to defend their direct-to-consumer ad budgets from political attacks, American Association of Advertising Agencies Senior VP John Kamp told the Food & Drug Law Institute Sept. 3 in Washington, D.C.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS030808

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel